Attached files
| file | filename |
|---|---|
| EX-10.11 - EX-10.11 - Black Diamond Therapeutics, Inc. | exhibit1011_q42020.htm |
| EX-32.1 - EX-32.1 - Black Diamond Therapeutics, Inc. | exhibit321_q42020.htm |
| EX-31.2 - EX-31.2 - Black Diamond Therapeutics, Inc. | exhibit312_q42020.htm |
| EX-31.1 - EX-31.1 - Black Diamond Therapeutics, Inc. | exhibit311_q42020.htm |
| 10-K - 10-K - Black Diamond Therapeutics, Inc. | bdtx-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (File No. 333- 252627) and on Form S-8 (No. 333-236170) of Black Diamond Therapeutics, Inc. of our report dated March 25, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 25, 2021